News
Sixth patient treated
A sixth patient — the third to receive the full therapeutic dose — has been treated. The primary, secondary, and exploratory endpoints will be evaluated at 90 days post treatment (May 2018). See here for more details.
A sixth patient — the third to receive the full therapeutic dose — has been treated. The primary, secondary, and exploratory endpoints will be evaluated at 90 days post treatment (May 2018). See here for more details.
